EUVIMEDEUVIMED entdecken
Open Access

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019–2026

Renhao Wang iD, Umailla Naeem, Alexander O Everhart, Pinar Karaca Mandic, Stacie B Dusetzina, Kasia J Lipska iD, Rozalina G McCoy iD

Diabetes Care · 2026

DOI: 10.2337/dc26-0300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2026. Verfasst von Renhao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland Institute for Health Computing, North Bethesda, MD. Hauptthemen laut MEDLINE: Insulin, Health Expenditures, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE High insulin prices are a major barrier to diabetes management in the U.S. Since 2019, several states have implemented legislation to mitigate high out-of-pocket (OOP) costs for commercially insured individuals by setting caps on monthly OOP payments for insulin. In this study, we examine the reach of these policies. RESEARCH DESIGN AND METHODS We identified insulin OOP cap legislation enacted through 2026 for each state and Washington, DC. Using public data on diabetes prevalence and health insurance coverage, we identified the population eligible and exposed to OOP caps legislation: adults aged 18–64 years with diabetes, using insulin, enrolled in state-regulated commercial plans, and residing in states that enacted OOP caps legislation. We then estimated the number of commercially insured individuals using insulin still left unprotected due to 1) being enrolled in federally regulated plans, regardless of state of residence, or 2) being enrolled in state-regulated plans but living in states without OOP cap legislation. RESULTS By 2026, 29 states and Washington, DC, had enacted OOP caps on insulin, covering an estimated 0.99 million individuals with diabetes, using insulin, and enrolled in state-regulated commercial plans. Despite these gains, policy reach remains uneven: 0.67 million adults with diabetes using insulin and insured by state-regulated plans live in states without an insulin OOP cap, and 2.2 million more are insured by federally regulated commercial plans that fall outside of state jurisdiction. CONCLUSIONS State OOP caps have the potential to reduce OOP insulin costs for many commercial plan enrollees but have limited reach. Legislative efforts to contain costs at the federal level are therefore needed to decrease the financial burden of insulin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinHealth ExpendituresDiabetes MellitusHumansUnited StatesAdultMiddle AgedAdolescentFemaleInsurance, HealthYoung AdultMaleInsurance Coverage

Substanzen

Insulin

Autor:innen und Institutionen

  • University of Maryland Institute for Health Computing, North Bethesda, MD.
  • Division of Endocrinology, Diabetes, & Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
  • University of Maryland School of Medicine, Baltimore, MD.
  • Washington University School of Medicine in St. Louis, St. Louis, MO.
  • Center for Advancing Health Services, Policy & Economics Research, Washington University, St. Louis, MO.
  • Department of Finance, Carlson School of Management, University of Minnesota, Minneapolis, MN.

ORCID-Profile: Renhao Wang, Kasia J Lipska, Rozalina G McCoy

Förderung

  • NIDDK NIH HHS
  • American Diabetes Association
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Wang, R., Naeem, U., Everhart, A. O., Karaca Mandic, P., Dusetzina, S. B., Lipska, K. J., & McCoy, R. G. (2026). State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019–2026. Diabetes Care. https://doi.org/10.2337/dc26-0300

Vancouver

Wang R, Naeem U, Everhart AO, Karaca Mandic P, Dusetzina SB, Lipska KJ, et al. State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019–2026. Diabetes Care. 2026. doi:10.2337/dc26-0300

BibTeX
@article{Wang2026,
  author = {Wang, Renhao and Naeem, Umailla and Everhart, Alexander O and Karaca Mandic, Pinar and Dusetzina, Stacie B and Lipska, Kasia J and McCoy, Rozalina G},
  title = {State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019–2026},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-0300}
}
Kostenlos starten →